Trequinsin hydrochloride
CAS No. 78416-81-6
Trequinsin hydrochloride( HL 725 )
Catalog No. M15958 CAS No. 78416-81-6
Trequinsin hydrochloride (HL 725) is a potent, cell-permeable, orally active inhibitor of cGMP-inhibited phosphodiesterase (PCE3 IC50=250 pM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 142 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrequinsin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrequinsin hydrochloride (HL 725) is a potent, cell-permeable, orally active inhibitor of cGMP-inhibited phosphodiesterase (PCE3 IC50=250 pM).
-
DescriptionTrequinsin hydrochloride (HL 725) is a potent, cell-permeable, orally active inhibitor of cGMP-inhibited phosphodiesterase (PCE3 IC50=250 pM), inhibits arachidonic acid-induced aggregation of human platelets with IC50 of 50 pM; reduces systemic blood pressure in both normotensive and hypertensive animal models.Hypertension Discontinued.
-
In VitroTrequinsin hydrochloride exerts besides its cardiovascular and antihypertensive qualities very potent antiplatelet activities.Trequinsin hydrochloride is an efficacious agonist of [Ca2+]i. Cell Viability Assay Cell Line:Samples from healthy volunteer research donors with normal sperm motility parameters in agreement with World Health Organization 2010 criteria.Concentration:10 μM.Incubation Time:20 min.Result:Caused a concentration dependent increase in [Ca2+]i (EC50 = 6.4 μM [95% confidence interval (CI): 4.1-9.9 μM]).
-
In Vivo——
-
SynonymsHL 725
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number78416-81-6
-
Formula Weight441.956
-
Molecular FormulaC24H28ClN3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (141.42 mM)
-
SMILESCC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2C)OC)OC)C.Cl
-
Chemical Name2,3,6,7-Tetrahydro-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-4H-pyrimido[6,1-a]isoquinolin-4-one hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lal B, et al. J Med Chem. 1984 Nov;27(11):1470-80.
2. Ruppert D, et al. Life Sci. 1982 Nov 8;31(19):2037-43.
3. Darius H, et al. Br J Pharmacol. 1985 Mar;84(3):735-41.
4. Blaskó G, et al. Thromb Res. 1986 Jul 15;43(2):249-50.
molnova catalog
related products
-
BPN14770 (b)
BPN14770 (BPN-14770) is an allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 and 7.4 nM for human PDE4D7 and PDE4D3 respectively.
-
Nortadalafil
Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
-
N-Ethyl tadalafil
N-Ethyl tadalafil (NEthyl tadalafil) is a CGMP-specific 3',5'-cyclic phosphodiesterase (PDE) inhibitor used in the study of cardiovascular diseases such as angina pectoris, hypertension, and pulmonary hypertension.
Cart
sales@molnova.com